Abstract
PHOSPHOLIPASES A2 (PLA2s) may be grouped into distinct families of proteins that catalyse the hydrolysis of the 2-acyl bond of phospholipids and perform a variety of biological functions. The best characterized are the small (relative molecular mass ˜ 14,000) calcium-dependent, secretory enzymes of diverse origin, such as pancreatic and venom PLA2s1. The structures and functions of several PLA2s are known2. Recently, high-resolution crystal structures of complexes of secretory PLA2s with phosphonate phospholipid analogues have provided information about the detailed stereochemistry of transition-state binding3, confirming the proposed catalytic mechanism of esterolysis4. By contrast, studies on mammalian nonpancreatic secretory PLA2s (s–PLA2s) have only recently begun; s–PLA2s are scarce in normal cells and tissues but large amounts are found in association with local and systemic inflammatory processes and tissue injury in animals and man5–7. Such s–PLAs have been purified from rabbit and rat inflammatory exudate8,9, from synovial fluid from patients with rheumatoid arthritis10,11 and from human platelets11. Cloning and sequencing shows that the primary structure of the human s-PLA211,12 has about 37% homology with that of bovine pancreatic PLA213 and 44% homology with that of Crotalus atrox PLA214. The human s-PLA2 is an unusually basic protein, yet contains most of the highly conserved amino-acid residues and sequences characteristic of the PLA2s sequenced so far1,15. Here we report the refined, three-dimensional crystal structure at 2.2 Å resolution of recombinant human rheumatoid arthritic synovial fluid PLA2. This may aid the development of potent and specific inhibitors of this enzyme using structure-based design.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Davidson, F. F. & Dennis, E. A. J. molec. Evol. 31, 228–238 (1990).
Waite, M. in Phospholipases (ed. Hanahan, D. J.) 155–241 (Plenum, New York, 1987).
Scott, D. L. et al. Science 250, 1541–1546 (1990).
Verheij, H. M. et al. Biochemistry 19, 743–750 (1980).
Vadas, P., Pruzanski, W. & Stefanski, E. Agents & Actions 24, 320–325 (1988).
Vadas, P. & Pruzanski, W. Lab Invest. 4, 391–404 (1986).
Chang, J., Musser, J. H. & McGregor, H. Biochem. Pharmac. 36, 2429–2436 (1987).
Forst, S. et al. Biochemistry 25, 8381–8385 (1986).
Chang, H. W., Kudo, I., Tomita, M. & Inoue, K. J. Biochem., Tokyo 102, 147–154 (1987).
Stefanski, E., Pruzanski, w., Sternby, B. & Vadas, P. J. Biochem., Tokyo 100, 1297–1303 (1986).
Kramer, R. M. et al. J. biol. Chem. 264, 5768–5775 (1989).
Seilhamer, J. J. et al. J. biol. Chem. 264, 5335–5338 (1989).
Fleer, E. A. M., Verheij, H. M. & deHaas, G. H. Eur. J. Biochem. 82, 261–269 (1978).
Randolph, A. & Heinrikson, R. L. J. biol. Chem. 257, 2155–2161 (1982).
Kramer, R. M., Johansen, B., Hession, C. & Pepinsky, R. B. Adv. exp. med. Biol. 275, 35–54 (1990).
Dijkstra, B. W., Kalk, K. H., Hol, W. G. J. & Drenth, J. J. molec. Biol. 147, 97–123 (1981).
Brunie, S., Bolin, J., Gewirth, D. & Sigler, P. B. J. biol. Chem. 260, 9742–9749 (1985).
White, S. P., Scott, D. L., Otwinowski, Z., Gelb, M. H. & Sigler, P. B. Science 250, 1560–1563 (1990).
Scott, D. L., Otwinowski, Z., Gelb, M. H. & Sigler, P. B. Science 250, 1563–1566 (1990).
Thunnissen, M. M. G. M. et al. Nature 347, 689–691 (1990).
Heinrikson, R. L. Meth. Emym. 197, 210–214 (1991).
Grinnell, B. W., Berg, D. T., Walls, J. & Yan, S. B. Biotechnology 5, 1189–1192 (1987).
Howard, A. J. et al. J. appl. Crystallogr. 20, 383–387 (1987).
Weiner, S. J. et al. J. Am. chem. Soc. 106, 765–784 (1984).
Weiner, S. J., Kollman, P. A., Nguyen, D. T. & Case, D. A. J. comput. Chem. 7, 230–252 (1986).
Brünger, A. T., Kuriyan, J. & Karplus, M. Science 235, 458 (1987).
Brünger, A. T. Acta crystallogr. A46, 46–57 (1990).
Hendrickson, W. A. & Konnert, J. H. in Biomolecular Structure, Function, Conformation and Evolution (ed. Srinivasan, R.) 1, 43–57 (Pergamon, Oxford, 1981).
Jones, T. A. J. appl. Crystallogr. 11, 268–272 (1978).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wery, JP., Schevitz, R., Clawson, D. et al. Structure of recombinant human rheumatoid arthritic synovial fluid phospholipase A2 at 2.2 Å resolution. Nature 352, 79–82 (1991). https://doi.org/10.1038/352079a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/352079a0
This article is cited by
-
Nonbactericidal secreted phospholipase A2s are potential anti-inflammatory factors in the mammary gland
Immunogenetics (2013)
-
Cancer-relevant biochemical targets of cytotoxic Lonchocarpus flavonoids: A molecular docking analysis
Journal of Molecular Modeling (2010)
-
Low Molecular Weight Phospholipases A2 in Mammalian Brain and Neural Cells: Roles in Functions and Dysfunctions
Molecular Neurobiology (2010)
-
Design of new secreted phospholipase A2 inhibitors based on docking calculations by modifying the pharmacophore segments of the FPL67047XX inhibitor
Journal of Computer-Aided Molecular Design (2010)
-
Refined structure of basic phospholipase A2 from venom ofAgkistrodon halys Pallas in orthorhombic crystal form I at 0.25 nm resolution
Science in China Series C: Life Sciences (1999)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.